Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ovarian tissue refers to the functional and structural components of the ovary, a paired female reproductive organ responsible for producing oocytes and synthesizing sex hormones such as estrogen and progesterone. The ovary is composed of an outer cortex containing follicles at various developmental stages, surrounded by a dense connective tissue capsule called the tunica albuginea. The inner medulla contains blood vessels and stroma. Ovarian tissue plays a central role in female fertility through gametogenesis and hormonal regulation of the menstrual cycle. It is not itself a molecular target but rather an anatomical structure made up of multiple cell types—including granulosa cells, theca cells, stromal fibroblasts—and extracellular matrix components[1][3]. In clinical research contexts such as fertility preservation or transplantation studies, "ovarian tissue" may refer to fragments or slices used for cryopreservation or culture[6]. However, it should not be considered a therapeutic target like receptors or enzymes; instead, specific molecules within ovarian tissue—such as connective tissue growth factor (CTGF) or kinases—may serve as actual drug targets in diseases like ovarian cancer[2][4]. Note on correctness: "Ovarian tissue" is not considered a canonical therapeutic target; it is an anatomical term describing part of an organ rather than a discrete molecule such as a receptor or enzyme. Therefore, this entry should be flagged as incorrect for use in structured drug-target databases that require molecular specificity. References directly support that "ovarian tissue" describes complex multicellular structures with diverse functions but does not represent a single actionable molecular entity suitable for targeted therapy development[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ovarian tissue.